Biocon moves up as its arm receives marketing authorisation for Vevzuo and Evfraxy in EU
Biocon is currently trading at Rs. 369.00, up by 0.60 points or 0.16% from its previous closing of Rs. 368.40 on the BSE. The scrip opened at Rs.…
Biocon is currently trading at Rs. 369.00, up by 0.60 points or 0.16% from its previous closing of Rs. 368.40 on the BSE. The scrip opened at Rs.…
Biocon is currently trading at Rs. 352.95, up by 2.40 points or 0.68% from its previous closing of Rs. 350.55 on the…
Biocon is currently trading at Rs. 260.55, up by 3.95 points or 1.54% from its previous closing of Rs. 256.60 on the…
Biocon is currently trading at Rs. 280.75, up by 0.65 points or 0.23% from its previous closing of Rs. 280.10 on the…
Biocon is currently trading at Rs. 314.30, up by 0.45 points or 0.14% from its previous closing of Rs. 313.70 on the…
Biocon is currently trading at Rs. 312.20, up by 1.90 points or 0.61% from its previous closing of Rs. 310.30 on the…
Biocon is currently trading at Rs. 372.40, up by 8.50 points or 2.34% from its previous closing of Rs. 363.90 on the…
Biocon is currently trading at Rs. 398.40, up by 7.45 points or 1.91% from its previous closing of Rs. 390.95 on the…
United States Food and Drug Administration (USFDA) has conducted a pre-approval inspection of Biocon’s new Oral Solid Dosage Forms manufacturing facility at…
Biocon has moved up in the Top 10 Global Biotech Employers ranking for 2018 and continues to be the only company from…